Codeine 30mg uses in Australia
The Co-ordination Group for Mutual Recognition and Decentralized Procedures – Human (CMDh) has reached a consensus on the implementation of new measures aimed at reducing the risk of serious side effects associated with the use of codeine-containing medicines for treating cough and cold in children. The newly agreed measures dictate that the use of codeine 30mg for cough and cold in children below 12 years is now contraindicated in Australia, meaning it must not be used in this patient group. Additionally, the use of codeine for cough and cold is not recommended in children and adolescents between 12 and 18 years who have breathing problems.
This decision is based on the understanding that the effects of codeine 30mg are attributed to its conversion into morphine in the body. Some Individuals metabolize codeine into morphine at a faster rate than normal, resulting in elevated levels of morphine in their blood, which can lead to serious effects, such as breathing difficulties.
Reviews
There are no reviews yet.